Skip to main content
Genexine, Inc. logo

Genexine, Inc. — Investor Relations & Filings

Ticker · 095700 ISIN · KR7095700001 KO Manufacturing
Open in API
Filings indexed 341 across all filing types
Latest filing 2022-12-28 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 095700

About Genexine, Inc.

http://www.genexine.com/

Genexine, Inc. is a clinical-stage biotechnology company focused on developing and commercializing immunotherapeutics and next-generation biologics. The company utilizes its proprietary hyFc® platform technology to create long-acting protein therapeutics. Its pipeline is led by GX-I7, a long-acting interleukin-7 designed to amplify T-cell counts for immuno-oncology applications. Other key assets in late-stage clinical trials include GX-E4, a long-acting treatment for anemia, and GX-H9 for growth hormone deficiency. Genexine's research and development efforts primarily target oncology and rare diseases.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(유무상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a decision on paid-in and free capital increases (유무상증자결정). It details the issuance of new shares, pricing, allocation ratios, and the purpose of the capital raise. This falls under the category of share issuance and capital changes.
2022-12-28 Korean
[기재정정]유상증자최종발행가액확정
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from Genexine regarding the finalization of the issue price for a paid-in capital increase (rights offering). It details the calculation of the final issue price, the number of shares, and includes a correction notice for a previous filing. This falls under capital structure changes and financing activities, specifically related to share issuance.
2022-12-28 Korean
[발행조건확정]증권신고서(지분증권)
Capital/Financing Update Classification · 100% confidence The document is a 'Securities Registration Statement' (증권신고서) filed with the Financial Services Commission (금융위원회) in South Korea. It details the finalization of issuance terms (발행조건확정) for a capital increase (유상증자) by Genexine. The document contains specific sections on the number of shares, offering price, and the rationale for the amendment (finalization of the issue price). This falls under the category of capital and financing updates.
2022-12-28 Korean
[기재정정]투자설명서
Investor Presentation Classification · 95% confidence The document is a 'Correction Report' (정정신고서) for an 'Investment Prospectus' (투자설명서) filed by Genexine. It details changes to the final offering price (from 15,500 KRW to 14,700 KRW) and updates related financial data, such as total offering amounts and dilution simulations. In the context of Korean regulatory filings (DART), this is a formal amendment to a securities registration statement/prospectus. Since the document is a detailed regulatory filing regarding capital changes and share issuance, it falls under the 'Share Issue/Capital Change' category.
2022-12-28 Korean
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure for an upcoming Annual General Meeting (AGM). It does not contain the full AGM materials or proxy statements, but rather serves as a formal regulatory notice of the procedural steps for the meeting. Given it is a standard regulatory announcement regarding corporate governance procedures, it fits best under the RNS category.
2022-12-12 Korean
[기재정정]주요사항보고서(유무상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) from Genexine, specifically detailing a decision regarding a capital increase (유무상증자결정). It outlines the terms of both paid-in and bonus share issues, including subscription dates, pricing methods, and board resolutions. This falls under the category of announcements regarding new share issues and capital structure changes.
2022-12-08 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.